Daunorubicin + Cytarabine + Venetoclax in de Novo AML
Daunorubicin + Cytarabine + Venetoclax in de Novo AML
Enrolling by invitation · NCT06697327 · Registry updated 2025-05-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Daunorubicin + Cytarabine + Venetoclax in de Novo AML | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Enrolling by invitation | Not applicable | 2025-05-14 | NCT06697327 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Anhui Medical University | 40 |
| The First Affiliated Hospital of Anhui Medical University | 85 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Department of Hematology, The First Affiliated Hospital of Anhui Medical University, 218 Jixi Road | Hefei | China | 2 |